CClinicalTrials.gg
CompletedNCT01083771Updated Mar 4, 2022Results posted

Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer

An interventional study of Olive Oil in Prostate Cancer, sponsored by Brown University. Completed at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-04.

Sponsored by Brown University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Not applicable
Ages
18 Years and older
Sex
Male
01

Study summary

The purpose of this study is to assess for changes in a patient's overall energy level and well-being (quality of life) after 8 weeks of dietary intervention.

Read the detailed description

Primary Objective: To assess for changes in the following measurements after 8 weeks of following a Mediterranean diet-- LDL, HDL, TG, FBS, creatinine, serum testosterone, triglycerides, serum insulin, CRP, 1bs, Waist circumference, blood pressure, body weight

02

Conditions studied

03

In context

Prostatic Neoplasms

6,370 studies on the registry are indexed under Prostatic Neoplasms; 1,400 are open to participants now.

This study's enrollment of 21 is below the median of 58 across 4,822 interventional studies indexed under Prostatic Neoplasms.

Browse Prostatic Neoplasms studies →

Lead sponsor

Brown University is the lead sponsor of 282 studies on the registry; 42 are open to participants now.

Of its 25 completed or terminated interventional studies of FDA-regulated products, 18 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Inclusion criteria

  • Histologically documented carcinoma of the prostate
  • On treatment with androgen deprivation therapy for at least 3 months
  • Required laboratory values:
  • Serum creatinine less than 2.5
  • Triglycerides \<300
  • Fasting glucose \< 126
  • Testosterone level \<50

Exclusion criteria

Exclusion Criteria:

  • No diabetes mellitus (Type 1 or 2)
  • No renal failure (Serum creatinine > 2.5)
  • No active cardiac disease -no history of myocardial infarction/stroke within the last 12 months, no recurrent unstable angina, uncontrolled/unstable arrhythmias, uncontrolled hypertension (systolic blood pressure >160, diastolic blood pressure >100)
  • No severe peripheral vascular disease
  • No commencement of lipid lowering agent within 8 weeks of enrollment the study or change in dose throughout the study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Olive Oil

    At least 3 tablespoons of olive oil each day

    Dietary Supplement: Olive Oil

Interventions

  • Dietary supplementOlive Oil

    Minimum of 3 tablespoon of olive oil per day

06

What researchers measure

Primary outcomes

  1. Changes in the Blood Chemistry (Fasting Triglycerides) After 8 Weeks of Following a Mediterranean Diet

    Based on overall percentage change at baseline versus post diet

    Time frame: eight weeks

Secondary outcomes

  1. To Assess Changes in the Body After 8 Weeks of Following a Mediterranean Diet

    Post diet waist circumference

    Time frame: 8 weeks

07

Results

Posted Jul 23, 2015

Participant flow

Participant flow — Overall Study
MilestoneOlive Oil
Started21
Completed16
Not completed5
Withdrew: Non-compliant2
Withdrew: Withdrawal by subject3

Outcome measures

PrimaryChanges in the Blood Chemistry (Fasting Triglycerides) After 8 Weeks of Following a Mediterranean Diet

Based on overall percentage change at baseline versus post diet

Time frame:
eight weeks
Reported as:
Mean · percentage of change
Changes in the Blood Chemistry (Fasting Triglycerides) After 8 Weeks of Following a Mediterranean Diet
percentage of changeOlive Oil
Changes in the Blood Chemistry (Fasting Triglycerides) After 8 Weeks of Following a Mediterranean Diet21 ± 38.2
SecondaryTo Assess Changes in the Body After 8 Weeks of Following a Mediterranean Diet

Post diet waist circumference

Time frame:
8 weeks
Reported as:
Mean · centimeters
To Assess Changes in the Body After 8 Weeks of Following a Mediterranean Diet
centimetersOlive Oil
To Assess Changes in the Body After 8 Weeks of Following a Mediterranean Diet102.4 ± 8.8

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Olive Oil—1/21 (4.8%)1/21 (4.8%)
Most frequent serious events
Most frequent serious events
EventOlive Oil
Chest painCardiac disorders1/21
Most frequent other events
Most frequent other events
EventOlive Oil
creatinine increasedBlood and lymphatic system disorders1/21

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Olive Oil
<=18 years0
Between 18 and 65 years10
>=65 years11
Age, Continuous
Age, Continuous(years)Olive Oil
Mean69.9 (58 to 80)
Sex: Female, Male
Sex: Female, Male(Participants)Olive Oil
Female0
Male21
Region of Enrollment
Region of Enrollment(participants)Olive Oil
United States21
08

Study locations

1 site
  • Miriam Hospital
    Providence, Rhode Island 02906, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01083771
Lead sponsor
Brown University
Collaborators
The Miriam Hospital
Responsible party
Sponsor
First posted
Mar 10, 2010
Start date
Feb 2009
Primary completion
Sep 2010
Completion
Aug 2012
Results posted
Jul 23, 2015
Last update
Mar 4, 2022

Study contacts

Anthony Mega, MD
principal investigator · The Miriam Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion